That article is dated 'Thursday, 21 May, 2015' and looks pretty...

That article is dated 'Thursday, 21 May, 2015' and looks pretty BS. That predates the 2016 regulatory changes lol. MC for export has not been licensed yet ZZZ

I have probably seen a bit more of the Aus industry than other MC investors - please explain what Auscann actually do at the moment and what their revenue streams are???

All they have is 'A STRONG TEAM WITH RELEVANT & COMPLEMENTARY SKILL-SETS, EXPERIENCE AND NETWORKS'
http://www.auscann.com.au/ That's a lot of caps for nothing at all, really (yes they have some partnerships and agreements but they are nothing of substance IMO)


MGC has a CBD Health strategy,
vertical integration,
European research facility (PANAX),
well advanced in growing their own MC,
well networked in Aus research (USYD) and tech scene (BuddingTech),
existing revenue stream (cosmetics),
clinical trials underway (Derma products),
developing more substantial revenue streams (Derma creams + API) ...
AND a key contender for Aus licensing with applications already lodged (to my knowledge)